• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group.

作者信息

Miravitlles M, Guerrero T, Mayordomo C, Sánchez-Agudo L, Nicolau F, Segú J L

机构信息

Servei de Pneumologia, Hospital General Universitari Vall d'Hebron, Barcelona, Spain.

出版信息

Respiration. 2000;67(5):495-501. doi: 10.1159/000067462.

DOI:10.1159/000067462
PMID:11070451
Abstract

BACKGROUND AND OBJECTIVE

The aim of this study was to develop and validate two models to estimate the probabilities of frequent exacerbations (more than 1 per year) and admissions for chronic obstructive pulmonary disease (COPD) that can be used in a primary care setting.

METHODS

Information was obtained in a cross-sectional observational study on ambulatory COPD patients performed in 201 general practices located throughout Spain. The model for admissions included 713 cases, 499 for the developmental sample and 214 in the validation sample; the model for frequent exacerbations included 896 patients, 627 in the developmental sample and 269 in the validation model. Candidate variables to be included in both models were: age, sex, body mass index (BMI), FEV(1) as percent predicted [FEV(1 )(% pred.)], active smoking, chronic mucus hypersecretion (CMH) and significant comorbidity.

RESULTS

The admission model contained 2 readily obtainable variables: comorbidity (OR = 1.97; CI 95% = 1. 24-3.14) and FEV(1)(% pred.) (OR = 0.72; 0.58-0.88, for every 10 units), and well calibrated in developmental and validation samples (goodness-of-fit tests: p = 0.989 and p = 0.720, respectively). The model for frequent exacerbations included 3 variables: age (OR = 1. 21; 1.01-1.44; for every 10 years of increasing age), FEV(1 )(% pred. ) (OR = 0.82; 0.70-0.96, for every 10 units) and CMH (OR = 1.54; 1. 11-2.14) and also well calibrated (p = 0.411 and p = 0.340 in the developmental and validation samples, respectively).

CONCLUSIONS

Our results suggest that FEV(1) impairment explains part of the risk of frequent exacerbations and hospital admissions. Furthermore, CMH and increasing age are significantly associated with the risk of frequent exacerbations, but severity of exacerbations provoking hospital admissions is associated with the presence of significant comorbidity. These important and easily measurable variables contain valuable information for optimal management of ambulatory patients with COPD.

摘要

相似文献

1
Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group.
Respiration. 2000;67(5):495-501. doi: 10.1159/000067462.
2
Acute exacerbation of COPD: factors associated with poor treatment outcome.慢性阻塞性肺疾病急性加重:与治疗效果不佳相关的因素
Chest. 2000 Mar;117(3):662-71. doi: 10.1378/chest.117.3.662.
3
Effect of tele health care on exacerbations and hospital admissions in patients with chronic obstructive pulmonary disease: a randomized clinical trial.远程医疗对慢性阻塞性肺疾病患者病情加重和住院的影响:一项随机临床试验。
Int J Chron Obstruct Pulmon Dis. 2015 Sep 3;10:1801-8. doi: 10.2147/COPD.S85596. eCollection 2015.
4
Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitación Obstructiva al Flujo aEreo.全科医疗中慢性阻塞性肺疾病及其急性加重的治疗。EOLO 研究组。气道阻塞受限的观察性研究。
Respir Med. 1999 Mar;93(3):173-9. doi: 10.1016/s0954-6111(99)90004-5.
5
How to predict exacerbations and hospital admissions in stable COPD outpatients.如何预测稳定期慢性阻塞性肺疾病门诊患者的病情加重和住院情况。
Respiration. 2000;67(5):491-2. doi: 10.1159/000067460.
6
Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects.在慢性阻塞性肺疾病(COPD)患者中,咳嗽和咳痰与频繁急性加重及住院相关。
Chest. 2009 Apr;135(4):975-982. doi: 10.1378/chest.08-2062. Epub 2008 Nov 18.
7
Exacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的急性加重、住院治疗及健康状况受损
Qual Life Res. 2006 Apr;15(3):471-80. doi: 10.1007/s11136-005-3215-y.
8
Frequency and risk factors of COPD exacerbations and hospitalizations: a nationwide study in Greece (Greek Obstructive Lung Disease Epidemiology and health ecoNomics: GOLDEN study).慢性阻塞性肺疾病急性加重和住院的频率及危险因素:希腊的一项全国性研究(希腊阻塞性肺病流行病学与健康经济学:GOLDEN研究)
Int J Chron Obstruct Pulmon Dis. 2015 Dec 11;10:2665-74. doi: 10.2147/COPD.S91392. eCollection 2015.
9
Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. DAFNE Study Group.慢性支气管炎急性加重门诊治疗后复发的相关因素。DAFNE研究组。
Eur Respir J. 2001 May;17(5):928-33. doi: 10.1183/09031936.01.17509280.
10
Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.泰国慢性阻塞性肺疾病(COPD)患者支气管扩张的存在与急性加重之间的关系。
Int J Chron Obstruct Pulmon Dis. 2018 Mar 2;13:761-769. doi: 10.2147/COPD.S139776. eCollection 2018.

引用本文的文献

1
Modelling of biological age in stable and acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病稳定期和急性加重期生物学年龄的建模
BMC Pulm Med. 2025 Aug 19;25(1):398. doi: 10.1186/s12890-025-03841-4.
2
Effective-Component Compatibility of Bufei Yishen Formula (ECC-BYF) III Inhibits Mucus Hypersecretion by BEAS-2B Cells via miR-146a-5p-Mediated Regulation of the EGFR/MEK/ERK Pathway.补肺益肾方Ⅲ号有效成分配伍通过miR-146a-5p介导的EGFR/MEK/ERK信号通路调控抑制BEAS-2B细胞黏液高分泌
Int J Chron Obstruct Pulmon Dis. 2025 Mar 10;20:623-639. doi: 10.2147/COPD.S498477. eCollection 2025.
3
Current Smoker: A Clinical COPD Phenotype Affecting Disease Progression and Response to Therapy.
当前吸烟者:一种影响疾病进展和治疗反应的慢性阻塞性肺疾病临床表型。
Am J Respir Crit Care Med. 2025 Feb 12;211(5):729-36. doi: 10.1164/rccm.202407-1379CI.
4
Development of a System for Predicting Hospitalization Time for Patients With Traumatic Brain Injury Based on Machine Learning Algorithms: User-Centered Design Case Study.基于机器学习算法的创伤性脑损伤患者住院时间预测系统的开发:以用户为中心的设计案例研究。
JMIR Hum Factors. 2024 Aug 30;11:e62866. doi: 10.2196/62866.
5
Development and Validation of Machine Learning-Based Models for Prediction of Intensive Care Unit Admission and In-Hospital Mortality in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.基于机器学习的慢性阻塞性肺疾病急性加重患者重症监护病房入住及院内死亡率预测模型的开发与验证
Chronic Obstr Pulm Dis. 2024 Sep 27;11(5):460-471. doi: 10.15326/jcopdf.2023.0446.
6
A prospective study on direct out-of-pocket expenses of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in a Philippine tertiary care center.菲律宾一家三级护理中心慢性阻塞性肺疾病急性加重住院患者直接自付费用的前瞻性研究。
BMC Pulm Med. 2024 Apr 17;24(1):184. doi: 10.1186/s12890-024-03011-y.
7
Analyses of Factors Associated with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Review.与慢性阻塞性肺疾病急性加重相关因素的分析:综述。
Int J Chron Obstruct Pulmon Dis. 2023 Nov 24;18:2707-2723. doi: 10.2147/COPD.S433183. eCollection 2023.
8
Risk Factors for Chronic Obstructive Pulmonary Disease Exacerbations among Individuals without a History of Recent Exacerbations: A COPDGene Analysis.无近期加重史个体慢性阻塞性肺疾病加重的危险因素:COPDGene 分析。
Ann Am Thorac Soc. 2024 Mar;21(3):421-427. doi: 10.1513/AnnalsATS.202209-751OC.
9
Estimating the Health and Economic Impact of Improved Management in Prevalent Chronic Obstructive Pulmonary Disease Populations in England, Germany, Canada, and Japan: A Modelling Study.评估英国、德国、加拿大和日本慢性阻塞性肺疾病患者改善管理后的健康和经济影响:一项建模研究
Int J Chron Obstruct Pulmon Dis. 2023 Sep 27;18:2127-2146. doi: 10.2147/COPD.S416988. eCollection 2023.
10
Re-admission and quality of life among patients with chronic obstructive pulmonary disease after telemedicine video nursing consultation - a randomized study.远程医疗视频护理咨询后慢性阻塞性肺疾病患者的再入院情况及生活质量——一项随机研究
Multidiscip Respir Med. 2023 Sep 11;18(1):918. doi: 10.4081/mrm.2023.918. eCollection 2023 Jan 17.